Therapeutic potential of phytochemicals for cystic fibrosis

被引:4
|
作者
Baharara, Hamed [1 ]
Kesharwani, Prashant [2 ,3 ]
Johnston, Thomas P. [4 ]
Sahebkar, AmirHossein [5 ,6 ,7 ]
机构
[1] Mashhad Univ Med Sci, Sch Pharm, Dept Clin Pharm, Mashhad, Iran
[2] Jamia Hamdard, Sch Pharmaceut Educ & Res, Dept Pharmaceut, New Delhi, India
[3] Saveetha Inst Med & Tech Sci, Saveetha Dent Coll, Ctr Transdisciplinary Res, Dept Pharmacol, Chennai, India
[4] Univ Missouri Kansas City, Sch Pharm, Div Pharmacol & Pharmaceut Sci, Kansas City, MO USA
[5] Mashhad Univ Med Sci, Pharmaceut Technol Inst, Biotechnol Res Ctr, Mashhad, Iran
[6] Mashhad Univ Med Sci, Appl Biomed Res Ctr, Mashhad, Iran
[7] Mashhad Univ Med Sci, Sch Pharm, Dept Biotechnol, Mashhad, Iran
关键词
baicalein; capsaicin; coumarin; curcumin; cystic fibrosis; genistein; phytomedicine; quercetin; resveratrol; TRANSMEMBRANE CONDUCTANCE REGULATOR; NATURAL COMPOUND CURCUMIN; CHLORIDE-CHANNEL; WILD-TYPE; SURFACE EXPRESSION; NUCLEOTIDE-BINDING; DELTA-F508; CFTR; CELL-CULTURE; IN-VITRO; GENISTEIN;
D O I
10.1002/biof.1960
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The aim of this review was to review and discuss various phytochemicals that exhibit beneficial effects on mutated membrane channels, and hence, improve transmembrane conductance. These therapeutic phytochemicals may have the potential to decrease mortality and morbidity of CF patients. Four databases were searched using keywords. Relevant studies were identified, and related articles were separated. Google Scholar, as well as gray literature (i.e., information that is not produced by commercial publishers), were also checked for related articles to locate/identify additional studies. The relevant databases were searched a second time to ensure that recent studies were included. In conclusion, while curcumin, genistein, and resveratrol have demonstrated effectiveness in this regard, it should be emphasized that coumarins, quercetin, and other herbal medicines also have beneficial effects on transporter function, transmembrane conductivity, and overall channel activity. Additional in vitro and in vivo studies should be conducted on mutant CFTR to unequivocally define the mechanism by which phytochemicals alter transmembrane channel function/activity, since the results of the studies evaluated in this review have a high degree of heterogenicity and discrepancy. Finally, continued research be undertaken to clearly define the mechanism(s) of action and the therapeutic effects that therapeutic phytochemicals have on the symptoms observed in CF patients in an effort to reduce mortality and morbidity.
引用
收藏
页码:984 / 1009
页数:26
相关论文
共 50 条
  • [1] CALNEXIN: A POTENTIAL THERAPEUTIC TARGET FOR MIGLUSTAT IN CYSTIC FIBROSIS
    Raveau, D.
    Becq, F.
    Norez, C.
    PEDIATRIC PULMONOLOGY, 2009, : 225 - 225
  • [2] Cystic fibrosis - therapeutic challenge in cystic fibrosis children
    Staab, D
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2004, 151 : S77 - S80
  • [3] Molecular targets for cystic fibrosis and therapeutic potential of monoclonal antibodies
    Moni, Sivakumar S.
    Al Basheer, Asmaa
    SAUDI PHARMACEUTICAL JOURNAL, 2022, 30 (12) : 1736 - 1747
  • [4] Ceramide in Cystic Fibrosis: A Potential New Target for Therapeutic Intervention
    Wojewodka, Gabriella
    De Sanctis, Juan B.
    Radzioch, Danuta
    JOURNAL OF LIPIDS, 2011, 2011
  • [5] Potential therapeutic agents for cystic fibrosis identified by high throughput screening
    Liang, L.
    Schwiebert, E.
    Guggino, W. B.
    PEDIATRIC PULMONOLOGY, 2007, : 295 - 295
  • [6] Therapeutic update in cystic fibrosis
    Durupt, S.
    Josserand, R. Nove
    Durieu, I.
    REVUE DE MEDECINE INTERNE, 2014, 35 (06): : 388 - 392
  • [7] Iron acquisition in the cystic fibrosis lung and potential for novel therapeutic strategies
    Tyrrell, Jean
    Callaghan, Maire
    MICROBIOLOGY-SGM, 2016, 162 : 191 - 205
  • [8] IκBα:: A potential anti-inflammatory therapeutic for cystic fibrosis
    Caldwell, S. M.
    Buff, S. M.
    Virella-Lowell, I.
    PEDIATRIC PULMONOLOGY, 2007, : 299 - 299
  • [9] THERAPEUTIC TARGETS FOR CYSTIC FIBROSIS
    Sorbera, L. A.
    Tremosa, L.
    Dulsat, C.
    DRUGS OF THE FUTURE, 2016, 41 (06) : 367 - 374
  • [10] THERAPEUTIC POTENTIAL OF RATTLESNAKE PLA2: IMPACT IN CYSTIC FIBROSIS
    Faure, Grazyna
    Corringer, Pierre-Jean
    Edelman, Aleksander
    TOXICON, 2018, 149 : 93 - 94